EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid

Katharina Davoudian iD, Sandro Spagnolo iD, Navina Lotay iD, Monika Satkauskas iD, Gábor Mészáros iD, Tibor Hianik iD, Zsófia Keresztes iD, Gilbert Walker, Michael Thompson iD

Biosensors · 2024

DOI: 10.3390/bios14060287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2024. Verfasst von Katharina Davoudian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada. Hauptthemen laut MEDLINE: Lysophospholipids, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Agency VEGA, European Union’s Horizon 2020 research and innovation program, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The overall 5-year survival rate of ovarian cancer (OC) is generally low as the disease is often diagnosed at an advanced stage of progression. To save lives, OC must be identified in its early stages when treatment is most effective. Early-stage OC causes the upregulation of lysophosphatidic acid (LPA), making the molecule a promising biomarker for early-stage detection. An LPA assay can additionally stage the disease since LPA levels increase with OC progression. This work presents two methods that demonstrate the prospective application for detecting LPA: the electromagnetic piezoelectric acoustic sensor (EMPAS) and a chemiluminescence-based iron oxide nanoparticle (IONP) approach. Both methods incorporate the protein complex gelsolin–actin, which enables testing for detection of the biomarker as the binding of LPA to the complex results in the separation of gelsolin from actin. The EMPAS was characterized with contact angle goniometry and atomic force microscopy, while gelsolin–actin-functionalized IONPs were characterized with transmission electron microscopy and Fourier transform infrared spectroscopy. In addition to characterization, LPA detection was demonstrated as a proof-of-concept in Milli-Q water, buffer, or human serum, highlighting various LPA assays that can be developed for the early-stage detection of OC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysophospholipidsOvarian NeoplasmsBiomarkers, TumorHumansFemaleBiosensing TechniquesGelsolinActinsEarly Detection of Cancer

Stichwörter der Autor:innen

EMPASactinantifouling linkeratomic force microscopychemiluminescencegelsolinlysophosphatidic acidnanoparticlesovarian cancer

Substanzen

Lysophospholipidslysophosphatidic acidBiomarkers, TumorGelsolinActins

Autor:innen und Institutionen

  • Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada.
  • Faculty of Mathematics, Physics and Informatics, Comenius University, Mlynská dolina F1, 842 48 Bratislava, Slovakia.
  • Functional Interfaces Research Group, Institute of Materials and Environmental Chemistry, HUN-REN Research Centre for Natural Sciences, Magyar tudósok krt. 2., H-1117 Budapest, Hungary.

ORCID-Profile: Katharina Davoudian, Sandro Spagnolo, Navina Lotay, Monika Satkauskas, Gábor Mészáros, Tibor Hianik, Zsófia Keresztes, Michael Thompson

Förderung

  • Science Agency VEGA
  • European Union’s Horizon 2020 research and innovation program
  • Canadian Institutes of Health Research

Zitieren

APA

Davoudian, K., Spagnolo, S., Lotay, N., Satkauskas, M., Mészáros, G., Hianik, T., Keresztes, Z., Walker, G., & Thompson, M. (2024). Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid. Biosensors. https://doi.org/10.3390/bios14060287

Vancouver

Davoudian K, Spagnolo S, Lotay N, Satkauskas M, Mészáros G, Hianik T, et al. Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid. Biosensors. 2024. doi:10.3390/bios14060287

BibTeX
@article{Davoudian2024,
  author = {Davoudian, Katharina and Spagnolo, Sandro and Lotay, Navina and Satkauskas, Monika and Mészáros, Gábor and Hianik, Tibor and Keresztes, Zsófia and Walker, Gilbert and Thompson, Michael},
  title = {Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid},
  journal = {Biosensors},
  year = {2024},
  doi = {10.3390/bios14060287}
}
Kostenlos starten →